Clinical Trial

SONATA LIFU for OCD

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The study tests ATTN201, an investigational non-invasive headband that delivers low-intensity focused ultrasound (LIFU) to the subthalamic nucleus (STN) as a treatment for obsessive-compulsive disorder (OCD). It's a randomized, double-blind, 1:1 (active: sham) study with 40 total participants spanning 12-16 weeks and 14 in-person and remote visits.
Trial Details
NCT Number NCT07728994
Lead Sponsor University of Pennsylvania
Collaborators: Attune Neurosciences Inc
Conditions Obsessive Compulsive Disorder
Enrollment 40 participants
Start Date 2026-07-01
Primary Completion 2028-07-31 (estimated)
Study Completion 2028-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-27